ARCHIVES

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

This article is from The Cancer Letter archive.

Vol. 02 No. 12 | March 19, 1976

Download PDF Visit The Full Archive

Related Articles

NCCN, McKesson Form Partnership To Build Clinical Support Software

November 30, 2012

Blacks Less Likely To Receive Standard Radiation Therapy

October 31, 2008

NCAB Okays Funding Core Grants For ICC, Hawaii, UC-San Diego

February 15, 1985

Reduced Risk of Metastasis When Screening Finds Cancer

August 27, 2004

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009